Technical Analysis for CYAD - Celyad SA

Grade Last Price % Change Price Change
grade F 22.59 0.44% 0.10
CYAD closed up 0.44 percent on Friday, January 18, 2019, on 2.32 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CYAD trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.44%
Jan 17 NR7 Range Contraction 0.44%
Jan 17 Wide Bands Range Expansion 0.44%
Jan 16 Outside Day Range Expansion 5.14%
Jan 16 Wide Bands Range Expansion 5.14%

Older signals for CYAD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.
Is CYAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.2
52 Week Low 15.36
Average Volume 9,795
200-Day Moving Average 27.6159
50-Day Moving Average 22.9856
20-Day Moving Average 20.266
10-Day Moving Average 22.707
Average True Range 1.6265
ADX 17.67
+DI 27.6466
-DI 23.1279
Chandelier Exit (Long, 3 ATRs ) 20.4805
Chandelier Exit (Short, 3 ATRs ) 20.2395
Upper Bollinger Band 25.8812
Lower Bollinger Band 14.6508
Percent B (%b) 0.71
BandWidth 55.414981
MACD Line 0.2024
MACD Signal Line -0.1732
MACD Histogram 0.3756
Fundamentals Value
Market Cap 215.17 Million
Num Shares 9.53 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -8.37
Price-to-Sales 41.08
Price-to-Book 6.10
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.54
Resistance 3 (R3) 23.57 23.28 23.38
Resistance 2 (R2) 23.28 23.04 23.27 23.32
Resistance 1 (R1) 22.94 22.89 22.80 22.91 23.27
Pivot Point 22.65 22.65 22.58 22.64 22.65
Support 1 (S1) 22.31 22.41 22.17 22.28 21.91
Support 2 (S2) 22.02 22.26 22.01 21.86
Support 3 (S3) 21.68 22.02 21.80
Support 4 (S4) 21.65